Katharine Darling

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


66 publications

2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2004 | 2003 | 2002 | 2000 | 1999 | 1996 | 1994 |
Incidence of sexually transmitted infections and association with behavioural factors: Time-to-event analysis of a large pre-exposure prophylaxis (PrEP) cohort.
Hovaguimian F., Kouyos R.D., Kusejko K., Schmidt A.J., Tarr P.E., Bernasconi E., Braun D.L., Calmy A., Notter J., Stoeckle M. et al., 2024/01. HIV medicine, 25 (1) pp. 117-128. Peer-reviewed.
 
Brief Report: Does Menopause Transition Influence Viral Suppression and Adherence in Women Living With HIV?
Hachfeld A., Atkinson A., Stute P., Calmy A., Tarr P.E., Darling KEA, Babouee Flury B., Polli C., Sultan-Beyer L., Abela I.A. et al., 2023/04/15. Journal of acquired immune deficiency syndromes, 92 (5) pp. 399-404. Peer-reviewed.
Successful implementation of new Swiss recommendations on breastfeeding of infants born to women living with HIV.
Crisinel P.A., Kusejko K., Kahlert C.R., Wagner N., Beyer L.S., De Tejada B.M., Hösli I., Vasconcelos M.K., Baumann M., Darling K. et al., 2023/04. European journal of obstetrics, gynecology, and reproductive biology, 283 pp. 86-89. Peer-reviewed.
 
Triggers of Change in Sexual Behavior Among People With HIV: The Swiss U U Statement and COVID-19 Compared.
Hamusonde K., Nicca D., Gnthard H.F., Stckle M., Darling KEA, Calmy A., Bernasconi E., Haerry D., Schmid P., Kouyos R.D. et al., 2023/02/01. The Journal of infectious diseases, 227 (3) pp. 407-411. Peer-reviewed.
CD4:CD8 Ratio and CD8 Cell Count and Their Prognostic Relevance for Coronary Heart Disease Events and Stroke in Antiretroviral Treated Individuals: The Swiss HIV Cohort Study.
Chammartin F., Darling K., Abela I.A., Battegay M., Furrer H., Calmy A., Bernasconi E., Schmid P., Hoffmann M., Bucher H.C. et al., 2022/12/15. Journal of acquired immune deficiency syndromes, 91 (5) p. 508. Peer-reviewed.
 
Sustained Effect on Hepatitis C Elimination Among Men Who Have Sex With Men in the Swiss HIV Cohort Study: A Systematic Re-Screening for Hepatitis C RNA Two Years Following a Nation-Wide Elimination Program.
Kusejko K., Salazar-Vizcaya L., Shah C., Stöckle M., Béguelin C., Schmid P., Ongaro M., Darling K., Bernasconi E., Rauch A. et al., 2022/11/14. Clinical infectious diseases, 75 (10) pp. 1723-1731. Peer-reviewed.
Unsupervised machine learning predicts future sexual behaviour and sexually transmitted infections among HIV-positive men who have sex with men.
Andresen S., Balakrishna S., Mugglin C., Schmidt A.J., Braun D.L., Marzel A., Doco Lecompte T., Darling K.E., Roth J.A., Schmid P. et al., 2022/10. PLoS computational biology, 18 (10) pp. e1010559. Peer-reviewed.
Women with HIV transitioning through menopause: Insights from the Swiss HIV Cohort Study (SHCS).
Hachfeld A., Atkinson A., Stute P., Calmy A., Tarr P.E., Darling K., Babouee Flury B., Polli C., Sultan-Beyer L., Abela I.A. et al., 2022/04. HIV medicine, 23 (4) pp. 417-425. Peer-reviewed.
Participation, retention and uptake in a multicentre pre-exposure prophylaxis cohort using online, smartphone-compatible data collection.
Hovaguimian F., Martin E., Reinacher M., Rasi M., Schmidt A.J., Bernasconi E., Boffi El Amari E., Braun D.L., Calmy A., Darling K. et al., 2022/02. HIV medicine, 23 (2) pp. 146-158. Peer-reviewed.
 
The association between depressive symptoms and neurocognitive impairment in people with well-treated HIV in Switzerland.
Santos G., Locatelli I., Métral M., Berney A., Nadin I., Calmy A., Tarr P., Gutbrod K., Hauser C., Brugger P. et al., 2021/07. International journal of STD & AIDS, 32 (8) pp. 729-739. Peer-reviewed.
The Impact of Binge Drinking on Mortality and Liver Disease in the Swiss HIV Cohort Study.
Surial B., Bertholet N., Daeppen J.B., Darling KEA, Calmy A., Günthard H.F., Stöckle M., Bernasconi E., Schmid P., Rauch A. et al., 2021/01/14. Journal of clinical medicine, 10 (2) p. 295. Peer-reviewed.
Alcohol consumption and neurocognitive deficits in people with well-treated HIV in Switzerland.
Darling KEA, Locatelli I., Benghalem N., Nadin I., Calmy A., Gutbrod K., Hauser C., Brugger P., Hasse B., Kovari H. et al., 2021. PloS one, 16 (3) pp. e0246579. Peer-reviewed.
Diagnosis of latent tuberculosis infection is associated with reduced HIV viral load and lower risk for opportunistic infections in people living with HIV.
Kusejko K., Günthard H.F., Olson G.S., Zens K., Darling K., Khanna N., Furrer H., Vetter P., Bernasconi E., Vernazza P. et al., 2020/12. PLoS biology, 18 (12) pp. e3000963. Peer-reviewed.
 
Antibodies against HPV16E6 oncoprotein in the Swiss HIV cohort study: Kinetics and anal cancer risk prediction.
Combes J.D., Clifford G.M., Günthard H.F., Hauser C., Darling KEA, Valladares P., Battegay M., Waldeck F., Bernasconi E., Bertisch B. et al., 2020/08/01. International journal of cancer, 147 (3) pp. 757-765. Peer-reviewed.
 
Authors' reply to A. Winston, A. Cotter, M. Gisslen, P. W. G. Mallon and P. Cinque.
Darling K., Métral M., Du Pasquier R., Cavassini M., Neurocognitive Assessment in the Metabolic and Aging Cohort (NAMACO) Study Group Swiss HIV Cohort Study, 2020/08. HIV medicine, 21 (7) pp. e19-e20. Peer-reviewed.
How helpful are the European AIDS Clinical Society cognitive screening questions in predicting cognitive impairment in an aging, well-treated HIV-positive population?
Metral M., Nadin I., Locatelli I., Tarr P.E., Calmy A., Kovari H., Brugger P., Cusini A., Gutbrod K., Schmid P. et al., 2020/05. HIV medicine, 21 (5) pp. 342-348. Peer-reviewed.
Clusters of Sexual Behavior in Human Immunodeficiency Virus-positive Men Who Have Sex With Men Reveal Highly Dissimilar Time Trends.
Salazar-Vizcaya L., Kusejko K., Schmidt A.J., Carrillo-Montoya G., Nicca D., Wandeler G., Braun D.L., Fehr J., Darling KEA, Bernasconi E. et al., 2020/01/16. Clinical infectious diseases, 70 (3) pp. 416-424. Peer-reviewed.
The Neurocognitive Assessment in the Metabolic and Aging Cohort (NAMACO) study: baseline participant profile.
Métral M., Darling K., Locatelli I., Nadin I., Santos G., Brugger P., Kovari H., Cusini A., Gutbrod K., Tarr P.E. et al., 2020/01. HIV medicine, 21 (1) pp. 30-42. Peer-reviewed.
Cross-Sectional and Cumulative Longitudinal Central Nervous System Penetration Effectiveness Scores Are Not Associated With Neurocognitive Impairment in a Well Treated Aging Human Immunodeficiency Virus-Positive Population in Switzerland.
Santos GMA, Locatelli I., Métral M., Calmy A., Lecompte T.D., Nadin I., Hauser C., Cusini A., Hasse B., Kovari H. et al., 2019/07. Open forum infectious diseases, 6 (7) pp. ofz277. Peer-reviewed.
 
Why do sub-Saharan Africans present late for HIV care in Switzerland?
Hachfeld A., Darling K., Calmy A., Ledergerber B., Weber R., Battegay M., Wissel K., Di Benedetto C., Fux C.A., Tarr P.E. et al., 2019/07. HIV medicine, 20 (6) pp. 418-423. Peer-reviewed.
 
Non-targeted HIV testing in the emergency department: not just how but where.
Tan R., Hugli O., Cavassini M., Darling K., 2018/12. Expert review of anti-infective therapy, 16 (12) pp. 893-905. Peer-reviewed.
 
Population-based outcome analysis of diffuse large B-cell lymphoma in people living with HIV infection and competent individuals.
Conconi A., Zucca E., Margiotta-Casaluci G., Darling K., Hasse B., Battegay M., Staehelin C., Novak U., Schmid P., Scherrer A. et al., 2018/12. Hematological oncology, 36 (5) pp. 757-764. Peer-reviewed.
Effect of national HIV testing recommendations and local interventions on HIV testing practices in a Swiss university hospital: a retrospective analysis between 2012 and 2015.
Lazzarino T., Martenet S., Mamin R., Du Pasquier R.A., Peters S., Perreau M., Muller O., Hugli O., Cavassini M., Darling KEA, 2018/10/03. BMJ open, 8 (10) pp. e021203. Peer-reviewed.
HIV testing history and access to treatment among migrants living with HIV in Europe.
Fakoya I., Álvarez-Del Arco D., Monge S., Copas A.J., Gennotte A.F., Volny-Anne A., Wengenroth C., Touloumi G., Prins M., Barros H. et al., 2018/07. Journal of the International AIDS Society, 21 Suppl 4 pp. e25123. Peer-reviewed.
Missed opportunities for HIV testing among patients newly presenting for HIV care at a Swiss university hospital: a retrospective analysis.
Lhopitallier L., Moulin E., Hugli O., Cavassini M., Darling KEA, 2018/06/12. BMJ open, 8 (6) pp. e019806. Peer-reviewed.
 
No Effect of Pegylated Interferon-α on Total HIV-1 DNA Load in HIV-1/HCV Coinfected Patients.
Strouvelle V.P., Braun D.L., Vongrad V., Scherrer A.U., Kok Y.L., Kouyos R.D., Stöckle M., Rauch A., Darling K., Hoffmann M. et al., 2018/05/25. The Journal of infectious diseases, 217 (12) pp. 1883-1888. Peer-reviewed.
 
A prospective multicentre study of healthcare provider preference in rapid HIV testing kits: Determine versus INSTI
Amyai N., Darling K., D'Acremont V., Castro E., Ebert S., Diserens M.M., Perdrix J., Fossati A.H., Bodenmann P., Cavassini M., 2018/01. International journal of STD & AIDS, 29 (1) pp. 51-56. Peer-reviewed.
Targeted versus non-targeted HIV testing offered via electronic questionnaire in a Swiss emergency department: A randomized controlled study.
Gillet C., Darling KEA, Senn N., Cavassini M., Hugli O., 2018. PloS one, 13 (3) pp. e0190767. Peer-reviewed.
Factors associated with syphilis incidence in the HIV-infected in the era of highly active antiretrovirals.
Shilaih M., Marzel A., Braun D.L., Scherrer A.U., Kovari H., Young J., Calmy A., Darling K., Battegay M., Hoffmann M. et al., 2017/01. Medicine, 96 (2) pp. e5849. Peer-reviewed.
Patient and doctor perspectives on HIV screening in the emergency department: A prospective cross-sectional study.
De Rossi N., Dattner N., Cavassini M., Peters S., Hugli O., Darling KEA, 2017. PloS one, 12 (7) pp. e0180389. Peer-reviewed.
Hepatitis C virus transmission among human immunodeficiency virus-infected men who have sex with men: Modeling the effect of behavioral and treatment interventions.
Salazar-Vizcaya L., Kouyos R.D., Zahnd C., Wandeler G., Battegay M., Darling K.E., Bernasconi E., Calmy A., Vernazza P., Furrer H. et al., 2016/12. Hepatology, 64 (6) pp. 1856-1869. Peer-reviewed.
 
Investigating Barriers in HIV-Testing Oncology Patients: The IBITOP Study, Phase I.
Merz L., Zimmermann S., Peters S., Cavassini M., Darling K.E., 2016/10. The oncologist, 21 (10) pp. 1176-1182. Peer-reviewed.
 
Trends in Incidences and Risk Factors for Hepatocellular Carcinoma and Other Liver Events in HIV and Hepatitis C Virus-coinfected Individuals From 2001 to 2014: A Multicohort Study.
Gjærde L.I., Shepherd L., Jablonowska E., Lazzarin A., Rougemont M., Darling K., Battegay M., Braun D., Martel-Laferriere V., Lundgren J.D. et al., 2016/09/15. Clinical infectious diseases, 63 (6) pp. 821-829. Peer-reviewed.
 
Dually Active HIV/HBV Antiretrovirals as Protection Against Incident Hepatitis B Infections: Potential for Prophylaxis.
Shilaih M., Marzel A., Scherrer A.U., Braun D.L., Kovari H., Rougemont M., Darling K., Battegay M., Hoffmann M., Bernasconi E. et al., 2016/08/15. The Journal of infectious diseases, 214 (4) pp. 599-606. Peer-reviewed.
 
Médecine d’urgence et prévention : une antinomie ? Réflexion à partir du dépistage VIH [Emergency medicine and prevention : a contradiction in terms ? Observations based on HIV screening]
Hugli O., Tagliabue L., Cavassini M., Darling K., 2016/08/10. Revue medicale suisse, 12 (526) pp. 1331-1335. Peer-reviewed.
 
Hepatitis C Virus Awareness Among Men Who Have Sex With Men in Southwest Switzerland.
Clerc O., Darling K., Calmy A., Dubois-Arber F., Cavassini M., 2016. Sexually Transmitted Diseases, 43 (1) pp. 44-48. Peer-reviewed.
 
Immunodeficiency and the risk of cervical intraepithelial neoplasia 2/3 and cervical cancer: A nested case-control study in the Swiss HIV cohort study.
Clifford G.M., Franceschi S., Keiser O., Schöni-Affolter F., Lise M., Dehler S., Levi F., Mousavi M., Bouchardy C., Wolfensberger A. et al., 2016. International Journal of Cancer, 138 (7) pp. 1732-1740. Peer-reviewed.
Late presentation to HIV care despite good access to health services: current epidemiological trends and how to do better.
Darling K.E., Hachfeld A., Cavassini M., Kirk O., Furrer H., Wandeler G., 2016. Swiss medical weekly, 146 pp. w14348. Peer-reviewed.
 
Consultations infectiologiques ambutatoires non VIH: analyse d'un centre universitaire sur cinq ans [Non-HIV infectious disease outpatient consultations: a 5-year study in a Swiss University Hospital].
Flückiger N., Moulin E., Merz L., Darling K., Cavassini M., 2015. Revue Médicale Suisse, 11 (470) pp. 850-855.
Patients' understanding of blood tests and attitudes to HIV screening in the emergency department of a Swiss teaching hospital: a cross-sectional observational study.
Favre-Bulle T., Baudat D., Darling K., Mamin R., Peters S., Cavassini M., Hugli O., 2015. Swiss Medical Weekly, 145 pp. w14206. Peer-reviewed.
Reasons for late presentation to HIV care in Switzerland.
Hachfeld A., Ledergerber B., Darling K., Weber R., Calmy A., Battegay M., Sugimoto K., Di Benedetto C., Fux C.A., Tarr P.E. et al., 2015. Journal of the International Aids Society, 18 (1) p. 20317. Peer-reviewed.
 
Virological outcome and management of persistent low-level viraemia in HIV-1-infected patients: 11 years of the Swiss HIV Cohort Study.
Boillat-Blanco N., Darling K.E., Schoni-Affolter F., Vuichard D., Rougemont M., Fulchini R., Bernasconi E., Aouri M., Clerc O., Furrer H. et al., 2015. Antiviral Therapy, 20 (2) pp. 165-175. Peer-reviewed.
Patients with AIDS-defining cancers are not universally screened for HIV: a 10-year retrospective analysis of HIV-testing practices in a Swiss university hospital.
Mosimann V., Cavassini M., Hugli O., Mamin R., Achtari C., Peters S., Darling K.E., 2014. Hiv Medicine, 15 (10) pp. 631-634. Peer-reviewed.
 
Seroprevalence of hepatitis e virus in domestic pigs and wild boars in Switzerland.
Burri C., Vial F., Ryser-Degiorgis M.P., Schwermer H., Darling K., Reist M., Wu N., Beerli O., Schöning J., Cavassini M. et al., 2014. Zoonoses and Public Health, 61 (8) pp. 537-544. Peer-reviewed.
An analysis of the benefit of using HEV genotype 3 antigens in detecting anti-HEV IgG in a European population.
Schnegg A., Bürgisser P., André C., Kenfak-Foguena A., Canellini G., Moradpour D., Abravanel F., Izopet J., Cavassini M., Darling K.E., 2013. Plos One, 8 (5) pp. e62980.
Awareness of HIV Testing Guidelines Is Low among Swiss Emergency Doctors: A Survey of Five Teaching Hospitals in French-Speaking Switzerland.
Darling K.E., de Allegri N., Fishman D., Kehtari R., Rutschmann O.T., Cavassini M., Hugli O., 2013. Plos One, 8 (9) pp. e72812.
 
Impact of recommendation updates in well-controlled patients on nonrecommended antiretroviral therapies: the Swiss HIV cohort study.
Boillat-Blanco N., Darling K.E., Taffe P., Osih R., Strahm C., Adami M., Elzi L., Daou S., Fehr J., Wandeler G. et al., 2013. Journal of Acquired Immune Deficiency Syndromes, 62 (2) pp. 180-189. Peer-reviewed.
 
Suboptimal access to primary healthcare among street-based sex workers in southwest Switzerland
Darling K.E., Gloor E., Ansermet-Pagot A., Vaucher P., Durieux-Paillard S., Bodenmann P., Cavassini M., 2013. Postgraduate Medical Journal, 89 (1053) pp. 371-375. Peer-reviewed.
 
A cross-sectional survey of attitudes to HIV risk and rapid HIV testing among clients of sex workers in Switzerland.
Darling K.E., Diserens E.A., N'garambe C., Ansermet-Pagot A., Masserey E., Cavassini M., Bodenmann P., 2012. Sexually Transmitted Infections, 88 (6) pp. 462-464.
 
An analysis of patients' understanding of 'routine' preoperative blood tests and HIV screening. Is no news really good news?
Albrecht E., Frascarolo P., Meystre-Agustoni G., Farron A., Gilliard N., Darling K., Cavassini M., 2012. HIV Medicine, 13 (7) pp. 439-443. Peer-reviewed.
Cerebral vasculitis complicating postoperative meningitis: the role of steroids revisited.
Darling K.E., Niederhauser J., Bervini D., Giulieri S., Daniel R.T., Bille J., Erard V., 2012. Swiss Medical Weekly, 142 (w13697) pp. 1-5.
HIV Testing Practices by Clinical Service before and after Revised Testing Guidelines in a Swiss University Hospital
Darling K.E., Hugli O., Mamin R., Cellerai C., Martenet S., Berney A., Peters S., Du Pasquier R.A., Bodenmann P., Cavassini M., 2012. Plos One, 7 (6) pp. e39299. Peer-reviewed.
 
Immune response to hepatitis B vaccination in HIV-positive adults with isolated antibodies to HBV core antigen.
Kaech C., Pache I., Bürgisser P., Elzi L., Darling K.E., Cavassini M., 2012. Journal of Infection, 65 (2) pp. 157-164.
 
Increased macrophage migration inhibitory factor (MIF) plasma levels in acute HIV-1 infection.
Delaloye J., De Bruin I.J., Darling K.E., Reymond M.K., Sweep F.C., Roger T., Calandra T., Cavassini M., 2012. Cytokine, 60 (2) pp. 338-340. Peer-reviewed.
Underreporting of needlestick and sharps injuries among healthcare workers in a Swiss University Hospital.
Voide C., Darling K.E., Kenfak-Foguena A., Erard V., Cavassini M., Lazor-Blanchet C., 2012. Swiss Medical Weekly, 142 (w13523) pp. 1-7.
Hepatitis E Virus Seroprevalence among Blood Donors in Southwest Switzerland.
Kaufmann A., Kenfak-Foguena A., André C., Canellini G., Bürgisser P., Moradpour D., Darling K.E., Cavassini M., 2011. Plos One, 6 (6) pp. e21150.
Hepatitis E Virus seroprevalence and chronic infections in patients with HIV, Switzerland.
Kenfak-Foguena A., Schöni-Affolter F., Bürgisser P., Witteck A., Darling K.E., Kovari H., Kaiser L., Evison J.M., Elzi L., Gurter-De La Fuente V. et al., 2011. Emerging Infectious Diseases, 17 (6) pp. 1074-1078.
 
Role of the cystic fibrosis transmembrane conductance regulator in internalization of Pseudomonas aeruginosa by polarized respiratory epithelial cells
Darling K. E., Dewar A., Evans T. J., 2004/06. Cell Microbiol, 6 (6) pp. 521-33.
 
Effects of nitric oxide on Pseudomonas aeruginosa infection of epithelial cells from a human respiratory cell line derived from a patient with cystic fibrosis
Darling K. E., Evans T. J., 2003/05. Infect Immun, 71 (5) pp. 2341-9.
 
Epithelial inducible nitric-oxide synthase is an apical EBP50-binding protein that directs vectorial nitric oxide output
Glynne P. A., Darling K. E., Picot J., Evans T. J., 2002. J Biol Chem, 277 (36) pp. 33132-8.
 
Heparin-induced thrombocytopaenia complicated by arterial and venous thrombosis: report of 2 cases successfully treated by a danaparoid sodium
Darling K., Jaumotte C., Saussoy P., Zech F., Lavenne E., Hainaut P., 2000. Acta Clin Belg, 55 (3) pp. 176-81.
 
Successful treatment of Candida glabrata endophthalmitis with amphotericin B lipid complex (ABLC)
Darling K., Singh J., Wilks D., 2000/01. J Infect, 40 (1) pp. 92-4.
 
Lactose intolerance with continuous veno-venous haemofiltration; the role of bicarbonate buffered haemofiltration
Forni L.G., Darling K., Evans M., Hilton P.J., Treacher D.F., 1999. Clin. Intensive Care, 9 pp. 40-42.
 
Surveillance of tuberculosis in Europe. Working Group of the World Health Organization (WHO) and the European Region of the International Union Against Tuberculosis and Lung Disease (IUATLD) for uniform reporting on tuberculosis cases.
Rieder H.L., Watson J.M., Raviglione M.C., Forssbohm M., Migliori G.B., Schwoebel V., Leitch A.G., Zellweger J.P., 1996. European Respiratory Journal, 9 (5) pp. 1097-1104.
 
Melanin and the regulation of mammalian photoreceptor topography
Jeffery G., Darling K., Whitmore A., 1994/04/01. Eur J Neurosci, 6 (4) pp. 657-67.
 
Changing trends in Vitamin A deficiency in children below five years of age
Rahmathullah L., Darling K., Raj P., Chandravathi R., Vennila R., 1994. Xeroph.Cl. Bull., 56 pp. 1-3.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University